Table 2. Tumor characteristic, dose, and dose coverage analysis of five patients.
| Patient No | location | size (cm) | Amplitude (cm) | regimine | D99(cGy) | D95(cGy) | D1(cGy) | V100(%) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ITV | GTV_4D | ITV | GTV_4D | ITV | GTV_4D | ITV | GTV_4D | |||||
| 1 | RL | 2.5 | 1.2 | 50Gy/5f | 4694(89.3%) | 5258 | 5048(92.8%) | 5440 | 6665(100.1%) | 6657 | 95.88%(−3.96%) | 99.84% |
| 2 | RL | 1.8 | 0.7 | 50Gy/4f | 4795(93.7%) | 5115 | 4980(95.3%) | 5223 | 5870(100.5%) | 5842 | 93.75%(−6.12%) | 99.87% |
| 3 | LU | 2.9 | 0.1 | 50Gy/4f | 4738(98.8%) | 4794 | 4936(99.3%) | 4972 | 5950(100.0%) | 5948 | 93.36%(−0.87%) | 94.23% |
| 4 | RU | 2.3 | 0.1 | 50Gy/5f | 4787(99.4%) | 4814 | 4949(99.2%) | 4991 | 5604(100.0%) | 5601 | 93.00%(−1.00) | 94.00% |
| 5 | LL | 1.8 | 0.9 | 50Gy/4f | 4846(96.2%) | 5037 | 4920(94.6%) | 5200 | 6343(99.9%) | 6348 | 92.99%(−6.59%) | 99.58% |
For location column, RL is right left lobe, LU is left upper lobe, RU is right upper lobe, and LL is left lower lobe.
For D99, D95, and D1 in ITV column, it both listed the absolute dose and the relative dose (in the brackets). The relative dose was the absolute dose of ITV relative to the absolute dose of GTV_4D (real target). For V100 in ITV column, the brackets listed the V100 difference (V100_ITV-V100_GTV_4D).